Medicine
Rivastigmine 4.6 mg/24 hours transdermal patch
Rivastigmine 4.6 mg/24 hours transdermal patch is a generic prescription medicine for transdermal use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
Key facts
- Active ingredient (INN)
- Rivastigmine
- Brand
- Sold under the generic name
- Strength
- 4.6 mg/24 hours
- Dosage form
- Transdermal patch
- Route
- Transdermal
- Packs
- 30 pouches, 30 patches and 5 more
- Manufacturers
- Zydus LifesciencesIndiaBryant Ranch PrepackAmneal PharmaceuticalsBreckenridge PharmaceuticalMylan PharmaceuticalsSandoz
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06DA03 Rivastigmine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 June 2015
- Identifiers
- RxCUI 725021, 725023, 1308569DailyMed set ID b201fe68-b5e5-4a6f-8cf1-069543f03e76, 8b671fc9-8cb0-4406-a9ee-7c95086d6200, 92a58ebb-748d-49f4-bf11-ecbcf5424152 +5NDC 51991-897, 65162-825, 0781-7304 +5Application ANDA209063, ANDA207308, NDA022083 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 pouch in 1 carton / 24 h in 1 pouch | 70710-1196-7 | Zydus LifesciencesIndia | 6 March 2019 |
| 30 pouch in 1 carton / 24 h in 1 pouch | 70771-1949-7 | Zydus LifesciencesIndia | 6 March 2019 |
| 30 patch in 1 carton / 24 h in 1 patch | 65162-825-34 | Amneal Pharmaceuticals | 30 June 2015 |
| 30 pouch in 1 carton / 1 patch in 1 pouch / 24 h in 1 patch | 51991-897-30 | Breckenridge Pharmaceutical | 19 December 2019 |
| 30 pouch in 1 carton / 1 patch in 1 pouch / 24 h in 1 patch | 0378-9070-93 | Mylan Pharmaceuticals | 20 June 2018 |
| 30 patch in 1 carton / 24 h in 1 patch | 0781-7304-31 | Sandoz | 2 September 2015 |
| 30 pouch in 1 carton / 1 patch in 1 pouch / 24 h in 1 patch | 63629-2065-1 | Bryant Ranch Prepack | 11 February 2021 |
| 30 pouch in 1 carton / 1 patch in 1 pouch / 24 h in 1 patch | 72162-1608-3 | Bryant Ranch Prepack | 19 December 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Rivastigmine 4.6 mg/24 hours transdermal patch.
Other strengths and forms of Rivastigmine
Clinical summary
Rivastigmine is a cholinesterase inhibitor indicated for treatment of mild, moderate, and severe dementia of the Alzheimer’s type (AD), among other approved uses. It is available as capsules and transdermal patches for oral use. MedsAcross supplies Rivastigmine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RivastigmineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Exelon prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Exelon: European public assessment report (EPAR) · European Medicines Agency
- Prometax: European public assessment report (EPAR) · European Medicines Agency
Need Rivastigmine 4.6 mg/24 hours transdermal patch for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.